技術-EN

Technology Available for Industry-Academia Collaboration or Technology Licensing. “An Aurora kinase inhibitor for precision targeting of MYC-amplified cancers” (2022/01/03)

Latest news-English, 產學研發-EN / 2022 年 1 月 3 日

1. Title: NHRI technology, “An Aurora kinase inhibitor …

Technology Available for Industry-Academia Collaboration or Technology Licensing. “An Aurora kinase inhibitor for precision targeting of MYC-amplified cancers” (2022/01/03) Read More »

本院公開徵選「幹細胞外泌體(Exosomes from Stem Cells) 之疾病治療技術」專屬授權技術移轉廠商 NHRI technology, “Exosomes from Stem Cells for Treatment” available for technology licensing

技術移轉招商, 技術移轉招商, 最新消息, 最新消息 / 2021 年 10 月 22 日

一、 主旨： 本院公開徵選「幹細胞外泌體(Exosomes from Stem Cells) 之疾病治療技術」 …

本院公開徵選「幹細胞外泌體(Exosomes from Stem Cells) 之疾病治療技術」專屬授權技術移轉廠商 NHRI technology, “Exosomes from Stem Cells for Treatment” available for technology licensing Read More »

NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17

Latest news-English, Latest news-English, Latest news-English, Latest news-English, 技術-EN, 技術-EN, 技術-EN, 技術-EN, 技術-EN / 2020 年 8 月 18 日

Subject NHRI technology, “Induction of Stem Cell-derive …

NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17 Read More »

  • Tel:+886-37-206166 #33201
  • Fax：+886-37-583287
  • Adress：No.35, Keyan Rd., Zhunan Township, Miaoli County 350 ,Taiwan